Zydus Lifesciences through its wholly owned subsidiary, and Perfect Day Inc., a Temasek portfolio company (Perfect Day) have signed an agreement wherein Perfect Day will sell its ~50% shareholding in Sterling Biotech (SBL). Post this transaction, Sterling Biotech will become a 50:50 Joint Venture (JV) with equal representation on the Board.
